Information Provided By:
Fly News Breaks for February 14, 2020
Feb 14, 2020 | 07:52 EDT
Cowen analyst Ryan Blicker raised his price target on DexCom to $300 from $250 as the company continues to fire on all cylinders and leaves plenty of room for upside. He believes investors underappreciate the magnitude of the earnings upside, and the non-intensive Type-2 progress being made in 2020. Blicker reiterated his Outperform rating on DexCom shares.
News For DXCM From the Last 2 Days
There are no results for your query DXCM